Bleeding versus stent thrombosis: can short DAPT be safe in

Tools & Techniques (TNT)
Bleeding versus stent
thrombosis:
can short DAPT be safe
in complex lesions?
With an unrestricted educational grant from
Biosensors International
Wednesday 20th May, 2015
16:50-18:20
ﬔeatre Bleu (Level 2)
Chairperson: P. Urban
Co-Chairperson: A. Abizaid
Panelists: S.J. Hong, A. Iniguez Romo, T. Kinnaird,
G. Sardella, D. Tresukosol
FEATURING BIOFREEDOM™ LIVE CASE TRANSMISSION
Live case center: Contilia Heart and Vascular Center, Essen, Germany
Operator: C. Naber
Booth at new location #F10+F11
www.biosensors.com
Tools & Techniques (TNT)
Attend this session if you want:
• To discuss changes in DAPT guidelines and their application in daily practice
• To identify the patient populations that suffer from bleeding complications
and cannot tolerate DAPT duration
• To understand how selection of a polymer-free stent can support
optimising treatment of patients
16:50 • A. Abizaid
Session objectives
16:55 • A. Iniguez Romo
Evidence for optimal DAPT duration following
stenting is inconclusive
17:01 • C. Naber
LIVE CASE TRANSMISSION
17:48
Time to React@PCR
18:03 • T. Kinnaird
Are polymer-free drug-coated stents
the solution for short DAPT?
18:09 • G. Sardella
Clinical evidence on the horizon
18:15 • P. Urban
Session evaluation and key learnings
BioFreedom n’est pas disponible à la vente en France et les informations le concernant ne sont pas destinées aux professionnels de la santé exerçant en France.
BioFreedom product is not available for sale in France and the information related to it is not intended for health care professionals who practice in France.
BioFreedom is a trademark or registered trademark of Biosensors International Group, Ltd. in the United States and other countries.
Not available for sale in the United States and certain other countries.
© 2015. Biosensors International Group, Ltd. All rights reserved.
www.biosensors.com